Ca 19-9 in the monitoring of colorectal cancer after surgery

被引：0
|
作者：
F. Franchi
C. Pastore
P. Izzo
E. Calió
机构：
[1] University of Rome ‘La Sapienza’,Department of Clinical Medicine, Oncology Unit
[2] University ‘Tor Vergata’,Department of Obstetrics and Gynecology
来源：
Medical Oncology | 2001年 / 18卷
关键词：
Colorectal cancer; CEA; Ca 19-9; marker sensitivity/specificity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：237 / 238
页数：1
相关论文
共 50 条
  • [21] CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma
    Pectasides, D
    Mylonakis, A
    Kostopoulou, M
    Papadopoulou, M
    Triantafillis, D
    Varthalitis, J
    Dimitriades, M
    Athanassiou, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (04): : 348 - 353
  • [22] Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer
    Reiter, W
    Stieber, P
    Reuter, C
    Nagel, D
    Lau-Werner, U
    Lamerz, R
    ANTICANCER RESEARCH, 2000, 20 (6D) : 5195 - 5198
  • [23] Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer: Second highest level of CA 19-9 in literature
    Kizilarslanoglu, Muhammet Cemal
    Civelek, Ramazan
    Kilic, Mustafa Kemal
    Kerem, Mustafa
    Gunaydin, Yusuf
    Ulger, Sukran
    JOURNAL OF BUON, 2014, 19 (02): : 583 - 584
  • [24] CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer
    Griesenberg, D
    Nürnberg, R
    Bahlo, M
    Klapdor, R
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2443 - 2450
  • [25] Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer
    Jo, Jae-Cheol
    Ryu, Min-Hee
    Koo, Dong-Hoe
    Ryoo, Baek-Yeol
    Kim, Hwa Jung
    Kim, Tae Won
    Choi, Kee Don
    Lee, Gin Hyug
    Jung, Hwoon-Yong
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kim, Jin-Ho
    Kang, Yoon-Koo
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) : 324 - 330
  • [26] Persistent elevation of serum CA 19-9 with no evidence of malignant disease
    Ventrucci, M.
    Pozzato, P.
    Cipolla, A.
    Uomo, G.
    DIGESTIVE AND LIVER DISEASE, 2009, 41 (05) : 357 - 363
  • [27] Role of Tumour Markers CEA and CA19-9 in Colorectal Cancer
    Sreedhar, Rashmi
    Jajoo, Suhas
    Yeola, Meenakshi
    Lamture, Yashwant
    Tote, Darshana
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2020, 9 (46): : 3483 - 3488
  • [28] Prognostic Significance of Preoperative Serum Carbohydrate Antigen 19-9 in Patients With Stage IV Colorectal Cancer
    Ozawa, Tsuyoshi
    Ishihara, Soichiro
    Kawai, Kazushige
    Nozawa, Hiroaki
    Yamaguchi, Hironori
    Kitayama, Joji
    Watanabe, Toshiaki
    Clinical Colorectal Cancer, 2016, 15 (04) : E157 - E163
  • [29] Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer
    Bombski, G
    Gasiorowska, A
    Orszulak-Michalak, D
    Neneman, B
    Kotynia, J
    Strzelczyk, J
    Janiak, A
    Malecka-Panas, E
    JOURNAL OF GASTROINTESTINAL CANCER, 2002, 31 (1-3) : 155 - 163
  • [30] Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
    Lakemeyer, Leilani
    Sander, Silvia
    Wittau, Mathias
    Henne-Bruns, Doris
    Kornmann, Marko
    Lemke, Johannes
    DISEASES, 2021, 9 (01)
12345